. Here we show that ferroptosis can be regulated non-cell-autonomously by cadherin-mediated intercellular interactions. In epithelial cells, such interactions mediated by E-cadherin suppress ferroptosis by activating the intracellular NF2 (also known as merlin) and Hippo signalling pathway. Antagonizing this signalling axis allows the protooncogenic transcriptional co-activator YAP to promote ferroptosis by upregulating several ferroptosis modulators, including ACSL4 and TFRC. This finding provides mechanistic insights into the observations that cancer cells with mesenchymal or metastatic property are highly sensitive to ferroptosis 8 . Notably, a similar mechanism also modulates ferroptosis in some non-epithelial cells. Finally, genetic inactivation of the tumour suppressor NF2, a frequent tumorigenic event in mesothelioma 10, 11 , rendered cancer cells more sensitive to ferroptosis in an orthotopic mouse model of malignant mesothelioma. Our results demonstrate the role of intercellular interactions and intracellular NF2-YAP signalling in dictating ferroptotic death, and also suggest that malignant mutations in NF2-YAP signalling could predict the responsiveness of cancer cells to future ferroptosis-inducing therapies.
. To study the underlying mechanisms further, we manipulated cellular metabolism by altering the ingredients of culture medium or cell number in culture. Unexpectedly, we observed that cells became more resistant to ferroptosis when approaching high confluence. In HCT116 human colon cancer cells, higher cell confluence conferred resistance to ferroptosis and associated lipid peroxidation, induced by cystine starvation, the cystine transporter inhibitor erastin and the GPX4 inhibitor RSL3 (Fig. 1a, b and Extended Data Fig. 1a-e) . Using corresponding pharmacological inhibitors, we confirmed that cells underwent ferroptosis rather than apoptosis or necroptosis under these conditions (Extended Data Fig. 1f, g ). Notably, previous published observations also suggest cell-density-dependent ferroptosis: GPX4-null mouse embryonic fibroblasts (MEFs) were able to grow when seeded at high density or as 3D spheroids, but died rapidly after passage at low density 12, 13 .
To examine whether such dependence on cell density is a general property of ferroptosis, we tested a panel of human epithelial cancer cell lines (Fig. 1c) . Most tested cell lines showed cell density dependence, with two exceptions: MDA-MB-231 (MDA231) cells were always sensitive to ferroptosis, whereas BT474 cells were always resistant, regardless of density. To better mimic the in vivo context, we cultured these cells into 3D tumour spheroids. Consistently, erastin triggered more prominent cell death in spheroids formed by MDA231 and H1650 cells (Fig. 1d, e) . A possible explanation for this phenomenon is that high cell density more rapidly depletes glutamine (required for cysteinedeprivation-induced ferroptosis 4, 14 ). However, replenishing glutamine to confluent cells did not restore cell death (Extended Data Fig. 1h ).
Cells tend to forge cell-cell contacts with higher cell confluence, and E-cadherin (ECAD) is an important mediator of intercellular contact in epithelial cells 15 . Expression of ECAD correlated with sensitivity to ferroptosis: ECAD was undetectable in MDA231 cells and very low in H1650 cells (Fig. 1f) . As cell density increased, ECAD expression increased and became enriched at sites of cell-cell contact in cells that underwent density-dependent ferroptosis; BT474 cells, which are resistant to ferroptosis regardless of confluence, expressed high levels of ECAD even at low cell density (Extended Data Fig. 2a-d ). Strong expression of ECAD was detected in spheroids generated from HCT116 cells, but not in those generated from MDA231 cells (Extended Data Fig. 2e ). To determine further whether ECAD has a causative role, we tested whether inhibition of ECAD dimerization would sensitize confluent cells to ferroptosis. Indeed, an anti-ECAD antibody that blocks its intercellular dimerization markedly increased the sensitivity of confluent cells to ferroptosis (Extended Data Fig. 2f ). ECAD depletion (ΔECAD) rendered confluent HCT116 cells sensitive to ferroptosis (Extended Data Fig. 2g-i) . ECAD depletion did not induce expression of N-cadherin (NCAD) in HCT116 cells (Extended Data Fig. 2g ). Re-expression of full-length ECAD, but not a truncated mutant lacking the ectodomain (required for intercellular dimerization of ECAD), restored resistance to ferroptosis in ΔECAD cells (Fig. 1g , h and Extended Data Fig. 2j, k) .
ECAD-mediated intercellular interaction can signal to the Hippo pathway 16, 17 , which regulates a plethora of biological events that includes control of proliferation and of organ size 18, 19 . The Hippo pathway involves the tumour suppressor NF2 and a kinase cascade consisting of MST1, MST2, LATS1 and LATS2. NF2 has been shown to activate the Hippo signalling pathway by inhibiting CRL4-DCAF1, a ubiquitin ligase complex that promotes proteasomal degradation of LATS1 or LATS2 20, 21 . LATS1 and LATS2 phosphorylate the prooncogenic transcription co-activator YAP, leading to its nuclear exclusion and inactivation. As expected, as HCT116 cells grew more confluent, increased phosphorylation and decreased nuclear localization of YAP were observed (Extended Data Fig. 3a, b) ; ECAD knockout or NF2 RNA interference (RNAi) diminished cell-density-regulated nuclear exclusion of YAP (Extended Data Fig. 3c-g, Supplementary Table 1 ). To confirm further that YAP is functionally activated under these conditions, we used an 8xGTIIC-luciferase reporter assay that monitors Letter reSeArCH the transcriptional activity of YAP (also known as YY1AP1) with its primary binding partners, the TEAD family of transcription factors 22 . Low cell density, loss of ECAD or NF2 RNAi all increased YAP activity and upregulated transcription of the canonical YAP targets CTGF and CYR61 (Extended Data Fig. 3h-l) . Knockdown of ECAD, NF2, LATS1 and LATS2 all sensitized HCT116 cells to ferroptosis in cell culture and spheroids (Fig. 1i-k and Extended Data Fig. 4a-c) . Notably, knockdown of ECAD, NF2, LATS1 and LATS2 did not decrease cell proliferation within the time frame of the experiment, ruling out the possibility that increased ferroptosis was due to reduced cell confluence (Extended Data Fig. 4d ). In addition, p21-activated kinase (PAK) can phosphorylate and inactivate NF2 17 . Consistently, constitutively active PAK (PAK-CAAX), but not its inactive mutant form (PAK-CAAX(K290R)), enhanced YAP activity and ferroptosis (Extended Data Fig. 4e-h ). Together, ECAD and Hippo signalling negatively regulate ferroptosis.
Heterozygous deletion and loss-of-function mutations of the NF2 gene are detected with high frequency in malignant mesothelioma, and inactivation of either NF2 or LATS1 or LATS2 is observed in approximately 50% of patients with malignant mesothelioma 10, 11 . We assessed NF2 status and ferroptosis sensitivity in a cohort of human malignant mesothelioma cell lines. Of ten patient-derived cell lines we examined, four had wild-type NF2 expression, and six were NF2-defective 21 ( Fig. 2a) . All NF2 wild-type cells expressed a cadherin protein (not necessarily ECAD) and either LATS1 or LATS2 (Fig. 2a and Extended Data Fig. 5a ). Several NF2-mutant cell lines can undergo potent ferroptosis even at the highest tested density and in spheroids, whereas all NF2 wild-type cells were relatively insensitive to ferroptosis under the same conditions (Fig. 2b, c and Extended Data Fig. 5b ). Consistently, NF2 RNAi sensitized confluent NF2 wild-type 211H cells to ferroptosis (Fig. 2d , e and Extended Data Fig. 5c, d) , and NF2 reconstitution in confluent, NF2-defective Meso33 cells decreased nuclear localization of YAP and mitigated ferroptosis (Extended Data Fig. 5e-h ). Furthermore, we generated a doxycycline (Dox)-inducible system to express NF2 in Meso33 cells (Fig. 2f) . Indeed, Dox-induced restoration of NF2 inhibited ferroptosis at high density and in a spheroid model (Fig. 2g, h and Extended Data Fig. 5i ).
Of the NF2 wild-type mesothelioma cells tested, only H-meso cells expressed ECAD (Fig. 2a) . 211H cells express NCAD in a manner dependent on cell density (Extended Data Fig. 6a ). We found that NCAD was similarly able to suppress ferroptosis in these cells and signal through the NF2-YAP axis (Extended Data Fig. 6b-k) . We also observed cell-density-dependent, NF2-regulated ferroptosis in MEFs, which are not of epithelial origin (Extended Data Fig. 7a-k) . Notably, we also observed a modest effect of cell density in a Burkitt lymphoma cell line, which does not express YAP or its homologue TAZ (Extended Data Fig. 7l-m) , suggesting an alternative mechanism (cystine production by transsulfuration could be a contributor, as previously reported 23 ). The correlation between YAP activity and ECAD-or NF2-regulated ferroptosis prompted us to perform additional functional experiments to determine whether YAP promotes ferroptosis. The YAP(S127A) mutant cannot be phosphorylated by LATS1 or LATS2 at the Ser127 residue, thus enhancing nuclear retention and transcriptional ) and cell viability was assayed by measuring cellular ATP levels (e). NS, not significant (P = 0.3757, 0.3572; from left to right). *P = 0.0323, **P = 0.0086, ***P = 0.0004, ****P < 0.0001; two-tailed t-test. f, Western blot of ECAD levels in the indicated cell lines. Image represents three experiments; see Supplementary Fig. 1 for raw blots. g, Ferroptosis after cystine starvation for 30 h in HCT116 cells depleted of ECAD using single-guide RNA (sgECAD) and in ECAD-depleted cells expressing full-length or ectodomain-truncated (Δecto) ECAD. **P = 0.0025, ***P = 0.0005; one-way analysis of variance (ANOVA). h, Viability of spheroids generated from cells as in g after treatment with erastin or dimethylsulfoxide (DMSO) control. NS, P = 0.8683. ***P = 0.0004, ****P < 0.0001; two-tailed t-test. i, Ferroptosis of HCT116 cells after cystine starvation for 30 h and the addition of 2 μM ferrostatin-1 (Fer-1). NS, P = 0.6880. ****P < 0.0001; one-way ANOVA. Note that shLATS1/2 #2 did not knockdown LATS2 (Extended Data Fig. 3e ) and thus did not sensitize cells to ferroptosis. j, Lipid ROS production of cells as in i. NS, P = 0.9383. ***P = 0.0001, ****P < 0.0001; one-way ANOVA. k, Viability of spheroids generated from HCT116 cells after the indicated treatments. **P = 0.0012, 0.0010 (left to right), ***P = 0.0002; one-way ANOVA. All data are mean ± s.d. from n = 3 biological replicates.
Letter reSeArCH regulatory activity even at high density 20, 24, 25 (Extended Data Fig. 8a-d ). HCT116 or 211H cells that express YAP(S127A) were markedly more sensitive to ferroptosis at high density or in spheroids ( Subsequently, we examined a range of putative YAP and TEAD gene targets that are known regulators of ferroptosis. Putative YAP-TEAD gene targets were selected from the TEAD4 ENCODE chromatin immunoprecipitation followed by high-throughput sequencing (ChIPseq) datasets GSM1010875 and GSM1010868. Among these genes, we found that transferrin receptor 1 (TFRC) and acyl-CoA synthetase long chain family member 4 (ACSL4)-both crucial mediators of ferroptosis 14, 26 -are genuine targets of the YAP-TEAD complex. Expression of TFRC and ACSL4 decreased with increasing cell density, and TFRC and ACSL4 were both upregulated by depletion of ECAD, knockdown of NF2 or overexpression of YAP(S127A) (Fig. 3e-h ). TEAD4 binds Dox. HA, haemagglutinin tag. g, Cells in the presence or absence of Dox after cystine starvation for 12 h. ***P = 0.0003; two-tailed t-test. h, Spheroids were grown in the presence or absence of Dox for 72 h, at which point 10 μM erastin was added. Cell viability was measured by ATP levels after 24 h. NS, P = 0.3393. **P = 0.0010; two-tailed t-test. All data are mean ± s.d. from n = 3 biological replicates. Cell death was measured after cystine starvation for 24 h. NS, P = 0.3525. **P = 0.0031; two-tailed t-test. b, Lipid ROS production of cells after cystine starvation for 16 h. *P = 0.0202, ***P = 0.0001; two-tailed t-test. c, Spheroids generated from parental HCT116 cells and YAP(S127A)-overexpressing cells were treated with erastin or DMSO as indicated, and cell viability was measured by cellular ATP levels. NS, P = 0.957. *P = 0.0200; two-tailed t-test. d, Ferroptosis of the indicated cells after cystine starvation for 24 h and transfection with non-targeting shRNA (shNT), NF2 shRNA (shNF2) or CRISPR-Cas9-mediated knockout of YAP (sgYAP). **P = 0.0043, ***P = 0.0004, ****P < 0.0001; one-way ANOVA. e, Western blot analysis of TFRC and ACSL4 in 211H cells seeded at increasing density. f, Western blot analysis of TFRC and ACSL4 in parental and ECADdepleted (ΔECAD) HCT116 cells. g, h, Western blot analysis of TFRC and ACSL4 in HCT116 (top) or 211H (bottom) cells transfected with shNT or shNF2 (g) or overexpressing YAP(S127A) (h). i, ChIP analysis of TEAD4 binding to the ACSL4 promoter in 211H cells using control immunoglobulin G (IgG) or an anti-TEAD4 antibody. Values are percentage of input. Quantitative PCR (qPCR) primers were designed based on TEAD4-binding peak regions depicted in the ENCODE TEAD4 ChIP-seq datasets. j, TEAD4 binding to the promoter region of TFRC was analysed as described in i. k, ChIP analysis monitoring the occupancy of TEAD4 on the ACSL4 and TFRC promoters in parental or YAP(S127A)-overexpressing 211H cells. Enrichment was calculated based on qPCR relative to the IgG control. *P = 0.0103, **P = 0.0079; two-tailed t-test. l, Cell death was measured in HCT116 cells expressing the indicated shRNAs after cystine starvation for 30 h. **P = 0.0072, ***P = 0.0004, ****P < 0.0001; one-way ANOVA. m, Cell death was measured in HCT116 cells expressing indicated shRNA and/or sgRNA, after cystine starvation for 30 h. ****P < 0.0001; one-way ANOVA. All data are mean ± s.d. from n = 3 biological replicates.
to the promoter regions of TFRC and ACSL4 genes, and binding was enhanced by overexpression of YAP(S127A) (Fig. 3i-k) . Confluent HCT116 cells were sensitized to ferroptosis after the expression of either TFRC or ACSL4, and co-expression of both further enhanced cell death (Extended Data Fig. 8m, n) . Conversely, reduced expression of TFRC or ACSL4 mitigated ferroptosis in sensitized cells (Fig. 3l , m and Extended Data Fig. 8o-r) . Together, these data indicate that upregulation of TFRC and ACSL4 contributes to the ability of YAP to promote ferroptosis. Notably, co-overexpression of TFRC and ACSL4 did not restore ferroptosis in confluent cells to the level of that in sparse cells, even when the ectopic ACSL4 level was higher than that in sparse cells (Extended Data Fig. 8m, n) , which suggests that additional YAP target genes contribute to this process. As loss of NF2 frequently drives mesothelioma 10, 11 , we examined whether NF2 status could predict mesothelioma sensitivity to ferroptosis. We generated Dox-inducible, CRISPR-Cas9-mediated GPX4-knockout (GPX4-iKO) 211H cells containing short hairpin RNA (shRNA) against NF2 (shNF2) or non-targeting shRNA (shNT) (Extended Data Fig. 9a ). Spheroids cultured after NF2 shRNA cells were more sensitive than shNT cells to GPX4 knockout-induced ferroptosis (Extended Data Fig. 9b ). We then used shNT-GPX4-iKO cells and shNF2-GPX4-iKO cells to produce subcutaneous xenograft tumours in athymic nude mice. In tumours, knockdown of NF2 increased the expression of TFRC, ACSL4 and nuclear YAP (Extended Data Fig. 9c ). The addition of Dox sharply reduced the expression of GPX4 in tumours; in NF2 RNAi tumours, Dox addition resulted in increased expression of the ferroptosis marker PTGS2 3 and reduced proliferation, as measured by Ki67 staining (Extended Data Fig. 9d) . Notably, after Dox addition, shNF2 tumours receded whereas shNT tumours only showed a decrease in growth (Fig. 4a and Extended Data Fig. 9e) . Similarly, knockdown of LATS1 and LATS2 rendered xenograft tumours generated by HCT116 cells significantly more sensitive to imidazole ketone erastin (IKE), an erastin derivative amenable for use in vivo 27 ( Fig. 4b and Extended Data Fig. 9f ). We next developed an intrapleural mouse model of mesothelioma, by orthotopically implanting shNF2-GPX4-iKO or shNT-GPX4-iKO cells containing a retroviral TK-GFP-luciferase (TGL) reporter. shNF2-GPX4-iKO cells grew more aggressively than shNT-GPX4-iKO cells in mice, consistent with the tumour-suppressive nature of NF2; the addition of Dox reduced the growth of shNF2 tumours, whereas shNT tumours were unaffected ( Fig. 4c and Extended Data Fig. 9g ). After euthanization, various organs were excised for bioluminescence imaging. shNT tumours grew within the pleural cavity, attaching to the aortic arch, lung or thoracic muscles, whereas shNF2 tumours metastasized to the pericardium, peritoneum, abdominal organs including liver, intestine and distal lymph nodes (Fig. 4d, e) -consistent with previous reports that NF2 loss enhances metastasis of mesothelioma 10 . Supporting this notion, spheroids cultured from NF2 shRNA cells extended more finger-like protrusions into Matrigel (Extended Data  Fig. 9h) . Importantly, the metastatic capability of NF2 shRNA tumours was reduced by Dox-induced knockout of GPX4 (Fig. 4d, e) . Therefore, NF2 status might be useful as a biomarker to predict mesothelioma metastasis and responsiveness to the induction of ferroptotic cell death.
Sorafenib, an orally administered multi-kinase inhibitor used for the treatment of hepatocellular carcinoma and renal cell carcinoma, also induces ferroptosis by inhibition of the x c − amino acid antiporter 28 . The potential for sorafenib as a therapy for malignant mesothelioma has been tested in clinical trials. The results suggest that sorafenib can stabilize the disease but achieves responses in only a small proportion of unselected patients 29, 30 . However, these trials did not examine the genetic status of the NF2-Hippo pathway. We found that sorafenib induced ferroptosis in a manner that is dependent on cell density and Hippo signalling (Extended Data Fig. 10a-g ). In addition, in epithelial cancer cells, decreased levels of ECAD, NF2 or Hippo pathway activity, and enhanced activation of YAP can promote epithelial-mesenchymal transition (EMT) and metastasis 19 . Consistently, as TGFβ can induce the expression of several EMT genes, it also enhanced ferroptosis in mammary tumour cells isolated from MMTV-neu mice at high cell density (Extended Data Fig. 10h-j) .
Collectively, we describe a non-cell-autonomous mechanism for the regulation of ferroptosis: neighbouring cells can have a considerable effect on the decision-making of ferroptosis via the . NS, P = 0.6776. ****P < 0.0001; two-way ANOVA. b, The indicated HCT116 cells were injected subcutaneously into nude mice (n = 6 per group). Tumours were grown to a volume of 90 mm 3 , at which point 50 mg kg −1 IKE was administered intraperitoneally daily for 12 days. NS, P = 0.9808. ***P = 0.0001, ****P < 0.0001; two-way ANOVA. For knockdown efficiency of LATS1 and LATS2, see Extended Data Fig. 3e . c, shNT-GPX4-iKO or shNF2-GPX4-iKO 211H cells were orthotopically injected into the pleural cavity of mice. The percentage change in the relative bioluminescent imaging (BLI) signal (photons s −1 ) versus timepoint 0 is shown. n = 6 (shNT − Dox) or 7 mice for each group. Box plots represent median ± interquartile range, whiskers represent the range of values. NS, P = 0.1545. *P = 0.0237, 0.0287 (top to bottom); two-way ANOVA. d, Bioluminescence imaging in excised organs, and in mouse bodies before and after organs were removed. e, Percentage of mice in each group with metastases in excised organs. shNT − Dox: n = 6; shNT + Dox, shNF2 − Dox, shNF2 − Dox: n = 7. H, heart; I, intestines/ mesenteric lymph nodes; K, kidneys L, lung; Li, liver; P, peritoneum; S, spleen. Data in a and b are mean ± s.d.
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cadherin-NF2-Hippo-YAP signalling axis. Considering that multicellular organisms are under frequent insult of oxidative stress, this intercellular mechanism might represent another layer of crucial defence to protect themselves from ferroptosis, a terminal consequence of oxidative stress.
Because cellular metabolism has a crucial role in ferroptosis, and enhanced proliferation often leads to stronger metabolism, it is possible that proliferation-stimulating oncogenic mutation may be a good predictor of ferroptosis sensitivity. However, previous publications argue against this view. For example, loss of function of the tumour suppressors p53 and BAP1 increases resistance, instead of sensitivity, to ferroptosis 5, 7 . Furthermore, unlike YAP(S127A), overexpression of the oncogenic PIK3CA(H1047R) mutant did not sensitize confluent 211H cells to ferroptosis, although both increased proliferation (Extended Data Fig. 10k-m) . Together, oncogenic mutations may affect ferroptosis by mechanisms other than enhancing proliferation.
As the cadherin-NF2-Hippo-YAP signalling axis is frequently mutated in cancer, this study has clear implications for cancer therapies-malignant alterations of several components in this signalling axis all sensitize cancer cells to ferroptosis. A potential concern about the feasibility of ferroptosis-inducing cancer therapy is whether there is any selectivity of the ferroptosis-inducing agents towards cancer cells compared with normal tissue. Our finding suggests that there might be a dose-responsive window for cancers that contain certain genetic signatures and that ferroptosis-inducing cancer therapies-if available (IKE and sorafenib hold potential for this purpose)-might have considerable benefits in overcoming cancer resistance to current treatments.
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Methods
Cell culture. MEFs, mouse NF639 cells, human epithelial tumour cells, and human mesothelioma cells were cultured in DMEM containing 10% fetal calf serum (FCS), 2 mM l-glutamine, 100 U ml −1 penicillin and 100 μg ml −1 streptomycin. CA-46 Burkitt lymphoma cells were cultured in RPMI medium supplemented with 20% serum and 100 U ml −1 penicillin and 100 μg ml −l streptomycin. The mesothelioma cell line panel was a gift from the Giancotti Laboratory. Media were prepared by the MSKCC Media Preparation Core Facility. All cell lines were subjected to STR authentication through ATCC and were tested for mycoplasma contamination. Generation of 3D spheroids. Spheroids were generated by plating tumour cells at 10 3 per well into U-bottom Ultra Low Adherence (ULA) 96-well plates (Corning). Optimal 3D structures were achieved by centrifugation at 600g for 5 min followed by addition of 2.5% (v/v) Matrigel (Corning). Plates were incubated for 72 h at 37 °C, 5% CO 2 , 95% humidity for formation of a single spheroid of cells. Spheroids were then treated with erastin in fresh medium containing Matrigel for the indicated time. Induction and inhibition of ferroptosis. To induce ferroptosis, cells with different density were seeded in 6-well plates. For cystine-starvation experiments, cells were washed twice with PBS and then cultured in cystine-free medium in the presence of 10% (v/v) dialysed FBS for the indicated time. The ferroptosis-inducing compounds erastin and RSL3 and the ferroptosis inhibitor ferrostatin-1 were purchased from Sigma-Aldrich. Measurement of cell death, cell viability and lipid peroxidation. Cell death was analysed by staining for propidium iodide (Invitrogen) or SYTOX Green (Invitrogen) followed by microscopy or flow cytometry. For 3D spheroids, cell viability was determined using the CellTiter-Glo 3D Cell Viability Assay (Promega) according to the manufacturer's instructions. Viability was calculated by normalizing ATP levels to spheroids treated with normal medium. To analyse lipid peroxidation, cells were stained 5 μM BODIPY-C11 (Invitrogen) for 30 min at 37 °C followed by flow cytometric analysis. Lipid ROS-positive cells are defined as cells with FITC fluorescence greater than 99% of the unstained sample. Immunoblotting. Nuclear and non-nuclear (membranes and cytosol) fractions were prepared as previously described. Proteins in the cell lysate were resolved on 8% or 15% SDS-PAGE gels and transferred to a nitrocellulose membrane. Membranes were incubated in 5% skim milk for 1 h at room temperature and then with primary antibodies diluted in blocking buffer at 4 °C overnight. The following primary antibodies were used: rabbit anti-GPX4, mouse anti E-cadherin, rabbit anti-N-cadherin, rabbit anti-NF2/Merlin, rabbit anti-transferrin receptor (Abcam, Cambridge), mouse anti-β-actin, mouse anti-Flag, mouse anti-HA (SigmaAldrich), rabbit anti-NF2/Merlin, rabbit anti-phospho-NF2/Merlin (Ser518), rabbit anti-LATS1, rabbit anti-LATS2, rabbit anti-YAP, rabbit anti-phospho-YAP (Ser127), mouse anti-CAS9, rabbit anti-p110α, mouse anti-AKT, rabbit anti-phospho-AKT (Ser473), rabbit anti-TAZ, rabbit anti-pan cadherin (Cell Signaling), rabbit anti-ACSL4 (Thermo Fisher), mouse anti-α-tubulin (Calbiochem), rabbit anti-GFP (Invitrogen). Goat anti-mouse or donkey anti-rabbit IgG (Invitrogen) conjugated to horseradish peroxidase (HRP) and an Amersham Imager 600 (GE Healthcare Life Sciences) was used for detection. Representative blots of at least two independent experiments are shown. After three washes, the membranes were incubated with goat anti-mouse HRP-conjugated antibody or donkey anti-rabbit HRP-conjugated antibody at room temperature for 1 h and subjected to chemiluminescence using Clarity Western ECL Substrate (Bio-Rad). Plasmids and cloning. pWZL Blast mouse E-cadherin and pWZL Blast DN E-cadherin were from the Weinberg Laboratory (Addgene plasmids 18804 and 18800, respectively). pRK5-Flag-HA-NF2 was from the Giancotti laboratory (Addgene plasmid 27104). The 8xGTIIC-luciferase reporter was from the Piccolo laboratory (Addgene plasmid 34615). mCherry-TFR-20 was from the Davidson laboratory (Addgene plasmid 55144). pQCXIH-Flag-YAP-S127A was from the Guan laboratory (Addgene plasmid 33092). pBABE-Flag-HA-NF2 was generated by PCR from pRK5-Flag-HA-NF2 (primers listed in Supplementary Table 2) , digested by PacI and EcoRI FastDigest restriction enzymes (Thermo Fisher), and ligated into the empty pBABE-puro backbone using T4 ligase (NEB). FUWtetO-Flag-HA-NF2 was created by digesting pRK5-Flag-HA-NF2 with EcoRI and XbaI and was ligated into the FUW-tetO-MCS vector from the Piccolo laboratory (Addgene plasmid 84008). FUW-m2rtTA was from the Jaenisch laboratory (Addgene plasmid 20342). PIK3CA(H1047R) was a gift from the Cantley laboratory (Weill Cornell Medicine). Gene silencing and expression. Lentiviral vectors encoding shRNAs targeting human ECAD, human NCAD, human and mouse Nf2, human LATS1 and LATS2, and human TFRC were generated by the core facility of MSKCC and are listed in Supplementary Table 1. Lentiviruses were produced by the co-transfection of the lentiviral vector with the Delta-VPR envelope and CMV VSV-G packaging plasmids into 293T cells using PEI. Medium was changed 12 h after transfection. The supernatant was collected 48 h after transfection and passed through a 0.45-μm filter to eliminate cells. Cells were incubated with infectious particles in the presence of 4 μg ml −1 polybrene (Sigma-Aldrich) overnight and cells were given fresh complete medium. After 48 h, cells were placed under the appropriate antibiotic selection. Generation of constitutive and inducible CRISPR-Cas9-mediated gene knockouts. ECAD, YAP-and ACSL4-depleted cells were generated using the CRISPRCas9-mediated knockout system. HCT116 cells were transfected with a human ECAD CRISPR-Cas9 knockout plasmid (sc-400031), and HCT116-shNF2 cells were transfected with a human YAP CRISPR-Cas9 knockout plasmid (sc-400040) or a human ACSL4 CRISPR-Cas9 KO plasmid (sc-401649), all purchased from Santa Cruz Biotechnology. The target sequence was a pool of three different gRNA plasmids located within the coding DNA sequence fused to Streptococcus pyogenes Cas9 and GFP. Single GFP + cells were sorted using a BD FACSAria II cytometer (BD Biosciences) and a 96-well plate, and single-cell clones were tested by western blotting.
The lentiviral Dox-inducible Flag-Cas9 vector pCW-Cas9 and pLX-sgRNA were from E. Lander and D. Sabatini (Addgene plasmids 50661 and 50662, respectively). Guide RNA sequence CACGCCCGATACGCTGAGTG was used to target human GPX4. To construct the lentiviral sgRNA vector for GPX4, a pair of oligonucleotides (forward and reverse) was annealed, phosphorylated and ligated into pLX-sgRNA. Lentiviral particles containing the sgRNA or Cas9 vectors were produced by co-transfection of the vectors with the Delta-VPR envelope and CMV VSV-G packaging plasmids into 293T cells using PEI. Medium was changed 12 h after transfection and supernatant was collected 48 h after transfection. MSTO-211H cells in 6-well tissue culture plates were infected in pCW-Cas9 viruscontaining supernatant containing 4 μg ml −1 of polybrene. Twenty-four hours after infection, virus was removed, and cells were selected with 2 μg ml −1 puromycin. Single clones were screened for inducible Cas9 expression. Dox (2 μg ml ) was added to the culture medium for 3 days. Single clones with Cas9 expression were infected with GPX4 gRNA virus-containing supernatant containing 8 μg ml −1 polybrene. Twenty-four hours after infection, virus was removed and cells were selected with 10 μg ml −1 blasticidin. Single clones with Dox-inducible Cas9 expression and GPX4 knockout were amplified for further experiments, named GPX4-iKO MSTO-211H cells. ChIP assay. Cells were crosslinked in 0.75% formaldehyde for 15 min, and glycine was added to a final concentration of 125 mM for 5 min. After washing with cold PBS, cells were collected in PBS and sonicated on an ultrasonic homogenizer for 10 min at 20% power on ice to shear DNA to an average fragment size of 200-1,000 bp. Fifty microlitres of each sonicated sample was removed to determine the DNA concentration and fragment size. Cell lysates were incubated overnight with 20 μl Magna ChIP Protein A+G Magnetic Beads (EMD Millipore) and 10 μg ChIP grade TEAD4 antibody (Abcam) at 4 °C. Beads were collected, washed and treated with proteinase K for 2 h at 60 °C and RNase for 1 h at 37 °C. DNA was purified with a PCR purification kit (Qiagen). DNA fragments were assessed by quantitative PCR with reverse transcription (qRT-PCR) using the primer sequences listed in Supplementary Table 2 . Samples were normalized to input DNA. RNA extraction and qRT-PCR. RNA was extracted using the TRIzol reagent (Invitrogen). Samples were treated with chloroform (20%), vortexed briefly, and incubated at room temperature for 15 min. Samples were then centrifuged at high speed at 4 °C for 15 min. The aqueous phase was moved to a new tube and an equal volume of isopropanol was added. Samples were incubated at room temperature for 10 min, followed by centrifugation at high speed at 4 °C for 10 min. Pellets were washed in 95% ethanol, dried and resuspended in nuclease-free water. cDNA was synthesized using iScript cDNA Synthesis Kit according to the manufacturer's instructions (Bio-Rad). qRT-PCR was performed with IQ SYBR Green Supermix (Bio-Rad) in a CFX Connect Real-Time PCR Detection System (Bio-Rad). Primer sequences are listed in Supplementary Table 2 . In vivo xenograft mouse study. GPX4-iKO MSTO-211H cells were infected with lentiviral vectors encoding shRNAs targeting human NF2 or non-targeting control (shNT) (GeneCopoeia). The resulting cells were called 'shNT-GPX4-iKO' and 'shNF2-GPX4-iKO' MSTO-211H cells. Six-to eight-week-old female athymic nu/nu mice were purchased from Envigo. For subcutaneous tumour models, mice were injected in the right flank with 1 × 10 7 shNT-GPX4-iKO or shNF2-GPX4-iKO MSTO-211H cells suspended in 150 μl Matrigel. Tumours were measured with callipers every three days. When tumours reached a mean volume of 100 mm For shLATS1/2 subcutaneous tumour models, female athymic nu/nu mice aged 6-8 weeks were injected in the right flank with 2 × 10 6 shNT HCT116 cells or shLATS1/2 HCT116 cells. Tumours were measured with callipers daily. When tumours reached a mean volume of 90 mm 3 , mice were randomized into 4 groups and treated with vehicle (65% D5W (5% dextrose in water), 5% Tween-80, 30% PEG-400) or 50 mg kg −1 IKE (65% D5W (5% dextrose in water), 5% Tween-80, 30% PEG-400) via intraperitoneal injection once a day. At the end of the study, mice were euthanized with CO 2 and tumours were taken for measurement of weight. According to the IACUC protocol for these experiments, once any tumour exceeded a volume of 1,000 mm 3 , 1.5 cm in diameter or 10% of body weight, the mice would immediately be euthanized.
All protocols for mouse experiments were approved by the Memorial Sloan Kettering Cancer Center IACUC. Orthotopic pleural mesothelioma mouse model. shNT-GPX4-iKO and shNF2-GPX4-iKO MSTO-211H cells were infected with retroviral TK-GFP-luciferase (TGL) reporter vector. To develop the orthotopic mouse model of pleural mesothelioma, female NOD/SCID mice (Envigo) aged 6-8 weeks were used. Mice were anaesthetized using inhaled isoflurane and oxygen. Intrapleural injection of 2 × 10 6 shNT-GPX4-iKO-TGL or shNF2-GPX4-iKO-TGL MSTO-211H cells in 100 μl of serum-free medium via a left thoracic incision was performed to establish the orthotopic mesothelioma tumour model. Tumour growth was monitored by weekly BLI for luciferase and mice were monitored daily for survival. NOD/ SCID mice bearing tumours were anaesthetized using isoflurane and injected intraperitoneally with 50 mg kg −1 d-luciferin (Molecular Probes). BLI was measured with 18 filters (500-840 nm) in an IVIS Spectrum (PerkinElmer) 10 min after injection. During image acquisition, mice were maintained on isoflurane via nose cone. Bioluminescence images were acquired using an IVIS Spectrum. The BLI signal was reported as total flux (photons per second), which represents the average of ventral and dorsal flux. At the end-point of the study, the mice were injected with d-luciferase and euthanized 10 min later. Organs were exposed and the BLI signal was measured. After organs were excised, BLI images were taken again as described. Imaging analysis was performed using the Living Image software (Caliper Life Sciences) All protocols for mouse experiments were approved by the Memorial Sloan Kettering Cancer Center IACUC. Immunohistochemistry. Formalin-fixed, paraffin-embedded specimens were collected, and a routine H&E slide was first evaluated. Immunohistochemical staining was done on 5-μm-thick paraffin-embedded sections using mouse anti-NF2/ Merlin (Abcam), rabbit anti-GPX4 (Abcam), rabbit anti-PTGS2 (Cell Signaling), mouse anti-Ki67 (Cell Signaling), rabbit anti-ACSL4 (Thermo Fisher), rabbit anti-TFRC (Abcam) and rabbit anti-YAP (Cell Signaling) antibodies with a standard avidin-biotin HRP detection system according to manufacturer's instructions (anti-mouse/rabbit HRP-DAB Cell & Tissue Staining Kit, R&D Systems). Tissues were counterstained with haematoxylin, dehydrated and mounted. In all cases, antigen retrieval was done with the BD Retrievagen Antigen Retrieval Systems as per manufacturer's instructions. Tumour spheroid invasion assay. Spheroids were generated as described in 200 μl complete growth medium and cultured for 72 h after cell seeding. The ULA 96-well plates containing 3-day-old spheroids were placed on ice. One-hundred microlitres per well of growth medium was removed from the spheroid plates. Using ice-cold tips, 100 μl of Matrigel was transferred to each well and mixed gently with medium, avoiding disturbance of the spheroids. Plates were placed in an incubator at 37 °C to allow the Matrigel to solidify. One hour later, 100 μl per well of complete growth medium was added. Images for each tumour spheroid were taken 48 h later. Statistical analysis. All statistical analyses were performed using GraphPad Prism 6.0 Software. Data are presented as mean ± s.d. from three independent experiments. P values were determined by Student's two-tailed t-test, one-way ANOVA or two-way ANOVA as indicated in the figure legends. For ANOVA, adjustments were made for multiple comparisons by Dunnett or Tukey corrections as appropriate. Exact P values can be found in figure legends. In cases where more than one comparison has the same statistical range, values are listed as they appear from left to right in the corresponding panel. No statistical methods were used to predetermine sample size. Unless stated otherwise, the experiments were not randomized and investigators were not blinded to allocation during experiments and outcome assessment. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
Data availability
For western blot source data, see Supplementary Fig. 1 . For the gating strategy used for flow cytometry experiments, see Supplementary Fig. 2 . Raw data for all experiments are available as Source Data to the relevant figures. ChIP-seq datasets analysed in this article are publicly available in the ENCODE database under the identifiers GSM1010875 and GSM1010868. Fig. 1 | Intercellular contact suppresses ferroptosis. a, b, HCT116 cells were seeded at the indicated density in 6-well plates and cultured for 24 h. a, Ferroptosis was measured by SYTOX Green staining after cystine starvation for 30 h. Phase contrast and fluorescent images are overlaid (original magnification, ×100). b, Cell death was measured in HCT116 cells at different densities treated with 30 μM erastin for 30 h, quantified by SYTOX Green staining followed by flow cytometry. c, Lipid ROS production of cells in b was assessed by C11-BODIPY staining followed by flow cytometry after 24 h of erastin treatment d, Cell death was measured in HCT116 cells cultured at the indicated cell densities and treated with 5 μM RSL3 for 24 h. e, Lipid ROS production in HCT116 cells cultured at the indicated cell densities and treated with 5 μM RSL3 for 16 h. f, HCT116 cells were seeded at 5 × 10 4 cells per well, grown for 24 h, and treated with: 1 μM Fer-1; 50 μg ml −1 of the iron chelator deferoxamine (DFO); 20 μM of the pan-caspase inhibitor Z-VAD-FMK; or 10 μM of the RIPK3 inhibitor GSK'872, in complete medium or cysteine-free medium for 30 h, followed by cell death measurement. n.s., P = 0.9999, 0.1995 (left to right). **P = 0.0070, 0.0050; one-way ANOVA. g, Cell death was measured in HCT116 cells seeded at 5 × 10 4 cells per well, grown for 24 h and treated with 5 μM RSL3 or DMSO and inhibitors as in f for 24 h. n.s., P = 0.4989. *P = 0.0366, ****P < 0.0001; one-way ANOVA. h, Cell death analysis in HCT116 cells seeded at 8 × 10 5 cells per well, grown for 24 h and treated with cystine-free medium containing the indicated amounts of glutamine for 30 h. Cell death was measured by SYTOX Green staining followed by flow cytometry. n.s., P = 0.5156; oneway ANOVA. All data are mean ± s.d. from n = 3 biological replicates. Fig. 6 | NCAD suppresses ferroptosis in MSTO-211H cells in a density-dependent manner. a, Western blot analysis of the levels of NCAD, p-YAP and total YAP in 211H cells cultured at different cell densities. b, Knockdown efficiency of NCAD shRNA (shNcad #1 and #2) was assessed by western blot analysis in 211H cells infected with lentiviruses expressing shNCAD. c, Confluent or sparse shNT or shNCAD 211H cells, as indicated, were subjected to cystine starvation for 24 h, at which point cell death was monitored by SYTOX Green staining. Original magnification, ×100. d, Flow cytometric quantification of cell death in c. n.s., P = 0.8426. ***P = 0.0056, 0.0015 (left to right), ****P < 0.0001; one-way ANOVA. e, Confluent or sparse shNT or shNCAD 211H cells, as indicated, were treated with 1 μM RSL3 for 16 h, at which point cell death was measured by SYTOX Green staining followed by flow cytometry. n.s., P = 0.3012, *P = 0.0315, ****P < 0.0001; one-way ANOVA. f, Spheroids generated from shNT and shNCAD 211H cells were treated with 10 μM erastin for 24 h, and cell death was determined by SYTOX Green staining. Original magnification, ×40. g, Cell viability of spheroids described in f was assayed by measuring cellular ATP levels. n.s., P = 0.4365, ***P = 0.0006, ****P < 0.0001; two-tailed t-test. h, shNT or shNCAD 211H cells were plated at high density and YAP localization was assessed by immunofluorescence. Original magnification, ×400. i, Transcription levels of CTGF and CYR61 measured by qPCR 211H cells plated at high density and transfected with shNT or shNCAD. *P = 0.0108, **P = 0.0016, ***P = 0.0007, ****P < 0.0001; one-way ANOVA. j, YAP/ TEAD transcriptional activity in 211H cells transfected with shNT or shNCAD was measured by a luciferase assay using the 8xGTIIC-luciferase reporter. ***P = 0.0002, ****P < 0.0001; one-way ANOVA. All data are mean ± s.d. from n = 3 biological replicates.
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